Dr. Zonghai Li, Founder, Chairman of the Board, Chief Executive Officer, and Chief Scientific Officer of CARsgen Therapeutics, said, "2025 is a pivotal year for CARsgen Therapeutics. As we enter the ...
Worldline launches a c. €108 million reserved capital increase to its strategic investors, representing the first step in its contemplated c. €500 million share capital increase Paris, La Défense, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results